Imfinzi (durvalumab) - AstraZeneca
carboplatin - Generic mfg.
neoantigen DNA vaccine - Washington University School of Medicine in St. Louis, AstraZeneca
http://clinicaltrials.gov/ct2/show/NCT04397003
 
Jun 13, 2025
 
Next